I don’t agree with management being a joke. I feel that they have lead us in a very open way. I like the fact that they are pretty transparent and haven’t seen this as a common open information in other stocks. In fact it is just the opposite and you might get information once in a great while in other investments.
Are you wondering what is up with our direction and what we have in play? How many trials we have and what direction we are going for those trials? Do you know the answers to what I just stated. Well, if you pay attention you know everything that CYDY is doing in all facets of every arena we are in. Current trials and location of trials and possible revenue and CSP’s, and everything and anything that is on the agenda for the investor that is in tune with what is going on across the company. That is such a privilege to be “in the know” of what is going on. Nader tells us everything he is allowed to tell us.
Tell me... where else would you as a investor get more information? Granted you could do some due diligence and find out some of the information that is provided by the company but this company just is open beyond all other companies and just flat out tells you so you don’t have to do the searches. Do you feel that any of this information helps you with your investment? I know I do. Information is power as they say. How we use this information is what helps us make our decisions.
I personally don’t want to lose this pipeline of information and clarity that it is provided in. It may not always be perfect but I can judge what is brought foreword just like anyone else. I like the openness of all that is Nader and management. I worry that this investor group is nothing like the management we currently have because they file a notice and then don’t follow up with a plan. It just doesn’t make sense to me. Why file a attack against a company without offering a better plan or direction? It is a sign to me that nothing has been revealed by the 5%er’s because they don’t have a better plan or a direction but want control anyway. That to me is not a reason to attack the company. If you don’t have a top 100 CEO’s to offer than how do we know there would be an improvement over Nader. You can knock Nader in many ways but he has got us to what not only I believe is very close internationally to an approval but the interim trial results might just get us a domino effect in many countries.
We have missed the boat essentially in the USA for Critical patients due to improvements in SOC. We have a big group waiting in LH’s still. But have directed our trials to international paths and how smart was this? Ask yourself as an investor... is it the right time to test drive a new management team that could throw us into a spin of lost time while they try to figure things out and it delays us literally months or a year before they get us to the same place Nader and management can in a few months... for Covid to pan out for us we need it to happen quickly or we will miss the whole pandemic and have lost our first potential revenue. Is now the right time to risk another management team when our team seems like it is just around the corner if we hit interim trial results that look like they are designed much easier than our other trials before this? Some will say we should of done this or that in the protocols of the next two trials but give the benefit of the doubt to the management for what they have learned so far and know that we had direction from a different CRO and another regulator in Brazil’s FDA equivalent.
For me it just seems the wrong time to trust another group. One we don’t know their plan.
Are you wondering what is up with our direction and what we have in play? How many trials we have and what direction we are going for those trials? Do you know the answers to what I just stated. Well, if you pay attention you know everything that CYDY is doing in all facets of every arena we are in. Current trials and location of trials and possible revenue and CSP’s, and everything and anything that is on the agenda for the investor that is in tune with what is going on across the company. That is such a privilege to be “in the know” of what is going on. Nader tells us everything he is allowed to tell us.
Tell me... where else would you as a investor get more information? Granted you could do some due diligence and find out some of the information that is provided by the company but this company just is open beyond all other companies and just flat out tells you so you don’t have to do the searches. Do you feel that any of this information helps you with your investment? I know I do. Information is power as they say. How we use this information is what helps us make our decisions.
I personally don’t want to lose this pipeline of information and clarity that it is provided in. It may not always be perfect but I can judge what is brought foreword just like anyone else. I like the openness of all that is Nader and management. I worry that this investor group is nothing like the management we currently have because they file a notice and then don’t follow up with a plan. It just doesn’t make sense to me. Why file a attack against a company without offering a better plan or direction? It is a sign to me that nothing has been revealed by the 5%er’s because they don’t have a better plan or a direction but want control anyway. That to me is not a reason to attack the company. If you don’t have a top 100 CEO’s to offer than how do we know there would be an improvement over Nader. You can knock Nader in many ways but he has got us to what not only I believe is very close internationally to an approval but the interim trial results might just get us a domino effect in many countries.
We have missed the boat essentially in the USA for Critical patients due to improvements in SOC. We have a big group waiting in LH’s still. But have directed our trials to international paths and how smart was this? Ask yourself as an investor... is it the right time to test drive a new management team that could throw us into a spin of lost time while they try to figure things out and it delays us literally months or a year before they get us to the same place Nader and management can in a few months... for Covid to pan out for us we need it to happen quickly or we will miss the whole pandemic and have lost our first potential revenue. Is now the right time to risk another management team when our team seems like it is just around the corner if we hit interim trial results that look like they are designed much easier than our other trials before this? Some will say we should of done this or that in the protocols of the next two trials but give the benefit of the doubt to the management for what they have learned so far and know that we had direction from a different CRO and another regulator in Brazil’s FDA equivalent.
For me it just seems the wrong time to trust another group. One we don’t know their plan.
8
